SAT-LB073 SJX-653, a Novel Selective NK3 Antagonist, Demonstrates Activity on Pharmacodynamic Markers of NK3 Target Engagement

Background: NK3 antagonism is a clinically validated mechanism of action for treating menopausal vasomotor symptoms (“hot flashes”). In men, reductions of LH and T are sensitive pharmacodynamic markers of central NK3 antagonism, due to the known inhibitory effect of NK3 antagonists on GnRH pulsatili...

Descripción completa

Detalles Bibliográficos
Autores principales: Cormier, Jennifer, Boyce, Malcolm, van den Berg, Frans, Grau, Daniel, Turnquist, David, Corzo, Deya, Graham, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552009/
http://dx.doi.org/10.1210/js.2019-SAT-LB073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552009/
http://dx.doi.org/10.1210/js.2019-SAT-LB073

Ejemplares similares